All Things you want to Know About Asia-Pacific Medical Image Analysis Software Market!!

The Medical Image Analysis Software Market is expected to reach USD 4.5 billion by 2024, according to a new report by Grand View Research, Inc. The clinical urgency to incorporate medical image analysis software for the diagnosis of chronic diseases is presumed to fuel the market growth throughout the forecast period. Moreover, the increased use of electronic health records to efficiently store, manage, and distribute patient health information in the form of medical images is also contributing towards the market growth.

medical-image-analysis-software-market

Additionally, continuous advancements in the technology, such as computer-aided diagnosis (CAD) are expected to provide potential growth opportunities for the utilization of the new and improved medical image software tools in a wide range of disease application areas including cancer and urology.

The steady demand for diagnostic and treatment procedures with greater efficiency have consequentially boosted the industry share of the medical image analysis software tools with enhanced features. Improved image quality, high resolution, and multi-modal imaging platforms are the key associated benefits driving the physician preference, thereby fuelling the market demand. Furthermore, the incorporation of the software tools facilitates sharing of medical image records among physicians to facilitate rapid and accurate treatment delivery, thus the implied demand for the medical image analysis software systems. These aforementioned factors are expected to drive the emergence of the medical image analysis software market over the forecast period.

Access Full Research Report On Medical Image Analysis Software Market: http://www.grandviewresearch.com/industry-analysis/medical-image-analysis-software-market

Further key findings from the study suggest:

  • On the basis of software type, the stand-alone software segment is anticipated to grow at a lucrative CAGR of over 7.5% over the forecast period due largely to the associated benefits, such as the systems with a user-friendly interface in use, which eliminates the requirement of skilled workforce to operate these systems
  • In terms of modality, ultrasound imaging is expected to register a lucrative growth rate of over 8.9% in the coming eight years. According to a report by NCBI, the ultrasound imaging segment can detect around 92.5% of the breast lumps. Moreover, the use of high-frequency radiation is not involved, thus ensuring patient safety; the high diagnosis efficiency and patient safety factors are anticipated to further fuel this segment’s demand.
  • On the basis of applications, the cardiology segment is expected to register the fastest growth owing to the rising in corporation of medical imaging systems used for the diagnosis of cardiovascular diseases (CVDs), such as Merge Cardio, which integrates digital health records from various cardiology-based modalities thus furnishing cardiologists with comprehensive patient record files with additional features, such as remote location access, along with the high prevalence rate of the CVDs synergistically accelerating the growth of this segment.
  • Diagnostic centers are anticipated to grow at a lucrative CAGR amongst the end-use market segment as a consequence of the increasing number of imaging diagnostic labs and the government initiatives in this direction. For example, Moldovan Ministry of Health along with International Finance Corporation are trying to attract private sector investors through public-private partnerships to set up and modernize radiology and diagnostic imaging.
  • As of 2015, North America dominated the regional medical image analysis software market at over 33.0%as a result of the presence of leading industry players and the supportive reimbursement policies. The rising government funding directed towards improving the imaging facility is also a prime growth driver for this regional market.
  • Asia Pacific is expected to be growing at the fastest CAGR of over 9.0% during the forecast period due to the rising penetration of the medical imaging systems in fast emerging economies of the Asia pacific region, such as China and India, investments in the healthcare industry, high R&D intensity by the major market players, and the presence of untapped opportunities
  • Some key players catering to this industry are Philips Healthcare, Siemens Healthineers, Toshiba Medical Systems Corporation, ClaroNav, Inc., GE Healthcare, Agfa Gevaert Corporation, Spacelabs Healthcare, Inc., Aquilab GmbH, MIM Software, Inc., Merge Healthcare, Inc., Carestream Health, Inc., Esaote, Inc., Bruker Corporation, and Xinapse Systems Ltd.
  • These market players are adopting strategies, such as technological innovation, new product development, and strategic collaborations as well as mergers & acquisitions to maximize their industry share. In August 2015, GE Healthcare received an FDA approval for its low dose Computed Tomography for lung cancer screening thereby expanding its product portfolio.

Grand View Research has segmented the medical image analysis software market on the basis of software type, modality, application, end-user, and region:

Global medical image analysis software, software type outlook (Revenue, USD Million, 2013 – 2024)

  • Integrated Software
  • Stand-alone Software

Global medical image analysis software modality outlook (Revenue, USD Million, 2013 – 2024)

  • Tomography
    • CT (Computed Tomography)
    • MRI (Magnetic Resonance Imaging)
    • PET (Positron Emission Tomography)
    • SPET (Single-Photon Emission Tomography)
  • Ultrasound Imaging
  • Radiographic Imaging
  • Combined Modalities

Global medical image analysis software application outlook (Revenue, USD Million, 2013 – 2024)

  • Orthopedic
  • Dental
  • Neurology
  • Cardiology
  • Oncology
  • Obstetrics & Gynecology
  • Mammography
  • Urology & Nephrology

Global medical image analysis software end-use outlook (Revenue, USD Million, 2013 – 2024)

  • Hospitals
  • Diagnostic Centers
  • Research Centers

Medical image analysis software regional outlook (Revenue, USD Million, 2013 – 2024)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-medical-image-analysis-software-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Growing Frequency Of Chronic Diseases And Rising Number Of Healthcare Settings Are Driving Factor For The Remunerative Growth Of The Market

The global Vital Sign Monitoring Devices Market is expected to reach USD 7.1 billion by 2025, according to a new report by Grand View Research, Inc. Continuous efforts towards new product development, spurring demand for the home healthcare services, increasing prevalence of chronic diseases and rising number of healthcare settings are driving factor for the remunerative growth of the market.

us-vital-signs-monitoring-devices-market.png

Development of comprehensive vital sign monitors which can monitor blood pressure, pulse and temperature is notable example of the development in this sector. Moreover, development of wireless and portable devices improved patient compliance is focal area of the development for the vital sign monitoring devices.

The prevalence of chronic diseases is exponential over the decade, this can be accountable to the sedentary lifestyle, pollution and stress. As a result, the prevalence of diseases such as diabetes mellitus, hypertension, allergies and respiratory disorders has increased rapidly. Hence, government, independent healthcare organizations, and private players are engaged in creating awareness about to take precautionary and preventive measures. This increasing awareness has led to increased demand for these devices in hospital and home use.

Access Full Research Report on Vital Sign Monitoring Devices Market: http://www.grandviewresearch.com/industry-analysis/vital-signs-monitoring-market

Further Key Findings From the Study Suggest:

  • Blood pressure monitors held the largest share in product segment in 2016. This segment is also anticipated to exhibit sturdy growth over the forecast period.
  • Hospitals due to greater patient volumes and greater financing abilities held commanding share in end-user segment of vitals sign monitoring devices market.
  • On the hand, home healthcare is likely to grow as key end-user for the vital sign monitoring devices. Home healthcare is cost efficient option compared to hospitals.
  • North America is largest regional market for the vitals sign monitoring devices market in 2016. However, Asia Pacific owing to policy reforms, and economic developments is projected to exhibit fastest CAGR over the forecast period.
  • Some of the key players in vital sign monitoring devices market include Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, GE Healthcare, Masimo, Omron Healthcare, Contec Medical Systems Co. Ltd, A&D Company Ltd., Nonin Medical Inc., and SunTech Medical, Inc.
  • New product developments, collaborations, regional expansion, and mergers are key strategic initiatives undertaken.

Grand View Research has segmented the vital sign monitoring devices market by product, end-use and region:

Product Outlook (Revenue, USD Million; 2014 – 2025)

  • Blood Pressure Monitors
    • Mercury Blood Pressure Monitors
    • Aneroid Blood Pressure Monitors
    • Digital Blood Pressure Monitors
    • Ambulatory Blood Pressure Monitors
    • Blood Pressure Instrument Accessories
  • Pulse Oximeters
    • Table-Top/Bedside Pulse Oximeters
    • Fingertip Pulse Oximeters
    • Hand-Held Pulse Oximeters
    • Wrist-Worn Pulse Oximeters
    • Pediatric Pulse Oximeters
    • Pulse Oximeter Accessories
  • Temperature Monitoring Devices
    • Mercury Filled Thermometers
    • Digital Thermometers
    • Infrared Thermometers
    • Liquid Crystal Thermometer
    • Temperature Monitoring Device Accessories
  • Other Vital Sign Monitors

End-Use Outlook (Revenue, USD Million; 2014 – 2025)

  • Hospitals
  • Physician’s Office
  • Home Healthcare
  • Ambulatory Centers
  • Emergency Care Centers
  • Other Healthcare Settings

Regional Outlook (Revenue, USD Million; 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa
    • Saudi Arabia

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-vital-signs-monitoring-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Recent Technological Trends in Pharma Sector will have positive impact on Pharmaceutical Robots Market Over The Forecast Period

The global Pharmaceutical Robots Market is anticipated to reach USD 430.0 million by 2025, according to a new report by Grand View Research, Inc. This growth can be attributed to the flourishing pharmaceutical industry.

japan-pharmaceutical-robots-market.png

The pharmaceutical industry is flourishing due to huge R&D investments by global players. With increasing drug discovery and clinical trials, there is growing demand for robotics. To minimize workload and maintain higher levels of accuracy, automation has become a significant part of pharmaceutical manufacturing. It increases efficiency, prevents performance of repetitive activities, and avoids human error & contamination.

Technological advancement is an important factor driving growth. The use of robots & automated machines in the field of pharmaceuticals is still in its nascent stage and expected to grow in the near future. The automation industry has incorporated a few new techniques such as collaborative robots and laboratory automation.

Pharmaceutical robotic machines also minimize manufacturing costs by reducing labor. These machines are 3 to 4 times faster than humans and have the capacity to work for 24 hours. Reduction in production cost is expected to raise return on investment in the long run, thus driving demand for these products in the future.

Access Full Industry Research Report On Pharmaceutical Robots Market: http://www.grandviewresearch.com/industry-analysis/pharmaceutical-robots-market

Further Key Findings From the Study Suggest:

  • In 2016, traditional robots held the largest share due to their availability in different types, varied applications, and increased awareness
  • Collaborative robots are expected to witness highest growth over the forecast period owing to their ability to easily integrate with existing manufacturing environments and interact with humans
  • Picking and packaging segment dominated the market in 2016 since almost all types of robotic machines are primarily used for picking and packaging
  • Laboratory applications are anticipated to propel significant growth over the forecast period due to increasing laboratory automation and the need to reduce the risk of human contamination
  • Pharmaceutical companies were the biggest contributors to the growth of the market in 2016 owing to a growing number of new drug development and clinical trials
  • Asia Pacific dominated the market in 2016 and is also anticipated to be the biggest driver of growth due to high penetration of robotic machines in pharma companies in countries such as China and Japan
  • Some of the key players include FANUC America Corporation; Kawasaki Heavy Industries, Ltd.; ABB Ltd.; Seiko Epson Corporation; Denso Wave Inc.; Yaskawa Electric Corporation; Universal Robots A/S; and Marchesini Group S.p.A.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the pharmaceutical robots market on the basis of product, application, end-use, and region:

Pharmaceutical Robots Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Traditional Robots
    • Articulated Robots
    • SCARA Robots
    • Delta/Parallel Robots
    • Cartesian Robots
    • Dual-Arm Robots
  • Collaborative Pharmaceutical Robots

Pharmaceutical Robots Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Picking and Packaging
  • Inspection of Pharmaceutical Drugs
  • Laboratory Applications

Pharmaceutical Robots End-Use Outlook (Revenue, USD Million, 2014 – 2025)

  • Pharmaceutical Companies
  • Research Laboratories

Pharmaceutical Robots Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-pharmaceutical-robots-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Future Is Bright For Hemodynamic Monitoring Devices Market Due To Rising Prevalence Of Chronic Illness

The global Hemodynamic Monitoring Devices Market is expected to reach USD 1.4 billion by 2024, according to a new report by Grand View Research, Inc. The increasing demand for non-invasive monitoring techniques coupled with the rising prevalence of chronic illness is expected to drive the market over the forecast period.

hemodynamic-monitoring-devices-market.png

The hemodynamic monitoring market is influenced by new technologies such as echocardiography, thoracic electrical bio-impedance and others that maybe used to non-invasively monitor parameters such as cardiac output, arterial pressure, blood oxygen level, and central venous pressure.

Furthermore, the rising population of critically ill patients coupled with defective healthcare facilities with drawbacks, such as understaffing, is propelling market players to develop minimal invasive hemodynamic monitoring devices that may be used in clinical and home care settings. Along with the new product development, the market is also anticipated to witness the development of technologies that help in the early diagnosis of shock and sepsis.

Furthermore, efforts by key industry players to understand critical illnesses at molecular levels leading to the development of efficient assessment products are expected to be witnessed over the forecast period. Hence, all these company strategies and the research conducted are eventually expected to promote market growth over the forecast period.

Browse Full Research Report on Hemodynamic Monitoring Devices Market: http://www.grandviewresearch.com/industry-analysis/hemodynamic-monitoring-devices-market

Further key findings from the study suggest:

  • The disposables segment is anticipated to be the largest segment by 2024. The rising sale of hemodynamic monitoring systems and increasing applications of these systems in home care settings, hospitals, and clinics are expected to boost the segment growth.
  • The non-invasive devices segment is expected to be the fastest growing hemodynamic monitoring market. Risks that include the development of arrhythmias due to the use of pulmonary artery catheter and the development of other methodologies that measure the cardiac output, such as echocardiographs, are the vital impact rendering drivers.
  • Asia Pacific is anticipated to be the fastest growing regions and is anticipated to contribute to about 20.0% of the global revenue by 2024. The strengthening of the distribution channels by companies and the registration of products in countries, such as China, India, Australia, and others, are expected to support the growth over the forecast period. For instance, LiDCO Group, in their 2016 prelim report emphasized on its strategy of appointing new distributors for the Australian and South East Asian region.
  • Major industry players are Edward Lifesciences, LiDCO Group Plc, Deltex Medical, Philips Medical, GE Healthcare, Noninvasive Medical Technologies, Inc., Tensys Medical, Inc., Cardio-Dynamics International, and Drager Medical, Inc. As mentioned above, the new product development is expected to drive the market over the forecast period.
  • For instance, in March 2016, the LiDCO Group received the U.S. FDA approval for the LiDCO unity and launched the product in the European region. Along the same time, LiDCO also succeeded in registering itself in China to explore untapped territories and increase their global presence.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the Hemodynamic Monitoring Devices Market on the basis of product, type, end-use and regions.

Global Hemodynamic Monitoring Devices Product Outlook (Revenue, USD Million, 2014 – 2024)

  • Monitoring systems
    • Pulmonary artery catheters
    • Cardiac output monitors
    • Others
  • Disposables
    • Probes
    • Airflow Sensors
    • Circuits
    • Others
  • Services

Global Hemodynamic Monitoring Devices Type Outlook (Revenue, USD Million, 2014 – 2024)

  • Invasive Hemodynamic Monitoring System
  • Minimally Invasive Hemodynamic Monitoring System
  • Non-invasive Hemodynamic Monitoring System

Global Hemodynamic Monitoring Devices End-use Outlook (Revenue, USD Million, 2014 – 2024)

  • Hospitals
  • Catheterization Laboratories
  • Others

Hemodynamic Monitoring Devices Market Regional Outlook (Revenue, USD Million, 2014 – 2024)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-hemodynamic-monitoring-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Report Covers the Highlighting The Factors Supporting Growth And Showcasing Certain Developments That Will Affect The Market

The global Hemodialysis And Peritoneal Dialysis Market is expected to reach USD 108.5 billion by 2025, according to a new report by Grand View Research, Inc. Home-based dialysis treatment is anticipated to witness lucrative growth over the forecast period. Factors supporting this trend include; increasing development of small and automated products capable of providing treatment at home, rising number of individuals requiring daily procedures, growing number of individuals aptly trained to perform self-treatment, and initiatives by market participants toward raising education and training for home dialysis performance.

us-hemodialysis-and-peritoneal-dialysis-market.png

This industry is highly competitive with a few players holding relatively high proportion of the market share. However, the dominance of each player is in a separate region thereby limiting direct competition. For instance, Baxter generates higher revenue in Europe whereas Fresenius Medical Care AG & Co. KGaA gains higher revenue in the U.S. Companies to expand their revenues and profits anticipate this scenario to change over the forecast period owing to increasing globalization, and efforts.

Browse Full Research Report on Hemodialysis & Peritoneal Dialysis Market: http://www.grandviewresearch.com/industry-analysis/hemodialysis-peritoneal-dialysis-market

Further key findings from the study suggest:

  • Hemodialysis dominates the industry with over 80.0% of the market share. These processes are performed in centers as well as in home settings primarily for adults. This enhanced applicability and benefits in comparison to peritoneal dialysis are expected to promote growth.
  • Presence of treatment centers and skilled personnel in abundance to carry out procedures is expected to drive the growth for these services. Factors responsible for higher market share of services may be classified into rising number of centers, development of training courses for home-based patients, and rising number of patients requiring dialysis treatment.
  • Home-based procedures are anticipated to witness the fastest growth over the forecast period. Development of small & portable systems along with with rising healthcare literacy amongst patients are vital impact rendering drivers.
  • Regionally, Asia Pacific is predicted to contribute higher revenue share over the forecast period. Improving healthcare infrastructure, rising disposable income, and growing incidence of conditions such as diabetes within the region are expected to support growth.
  • Players highlighted in the study include Fresenius Medical Care AG & Co. KGaA, NIPRO Medical Corporation, B. Braun Avitum AG, Baxter, and DaVita Inc. These companies are aggressively working toward purchasing dialysis centers or establishing new centers to cater to the rising demand.

Read Our Blog: http://www.grandviewresearch.com/blog/hemodialysis-peritoneal-dialysis-market-size-share

Grand View Research has segmented the global hemodialysis and peritoneal dialysis market on the basis of type, product, end-use, and region:

Global Hemodialysis And Peritoneal Dialysis Type Outlook (Revenue, USD Million, 2014-2025)

  • Hemodialysis
    • Conventional
    • Short Daily
    • Nocturnal
  • Peritoneal Dialysis
    • CAPD
    • APD

Global Hemodialysis And Peritoneal Dialysis Product Outlook (Revenue, USD Million, 2014-2025)

  • Device
    • Machine
    • Dialyzers
    • Water Treatment System
    • Others
  • Consumables
    • Bloodline
    • Concentrates
    • Catheters
    • Others
  • Services

Global Hemodialysis And Peritoneal Dialysis End-use Outlook (Revenue, USD Million, 2014-2025)

  • Home-based
  • Hospital-based

Hemodialysis And Peritoneal Dialysis Regional Outlook (Revenue, USD Million, 2014-2025)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-hemodialysis-peritoneal-dialysis-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Global Microtome Market Size Was Estimated At USD 48.6 million in 2016 and is Estimated To Surpass $73.5 Million By 2025

The global Microtome Market is expected to reach USD 73.5 million by 2025, according to a new report by Grand View Research, Inc. Growing awareness about early diagnosis of chronic diseases and increasing demand for technologically advanced diagnostic equipment are some of the key factors anticipated to drive the microtome market.

us-microtome-market.png

According to the estimates of Laboratory Economics, in 2012, over USD 20 billion was spent on laboratory mergers between 1996 and 2011. In 2011, approximately USD 3.5 billion was spent on laboratory mergers. Increasing worldwide geriatric population, growing healthcare expenditure, and rising patient awareness regarding early disease diagnosis are some of the key factors expected to propel the tissue diagnostics market. This, in turn, is likely to boost demand for tissue slicing equipment. However, reimbursement cuts and hospital consolidation are some of the factors expected to hamper growth.

Although the U.S. ranks first in terms of per capita healthcare spending, spending on clinical laboratories is significantly lower as compared to other healthcare aspects. Moreover, overall growth in the clinical laboratory market is majorly dependent on demographic factors, technological, medical, & scientific advancements, and disease burden specific to that region. Developed economies, such as the U.S., Germany, Japan, Canada, and France, have huge R&D budgets, higher technological advancements, and more awareness regarding various health aspects as compared to developing economies. This is likely to account for majority of the share in these regions.

Growing number of histopathology laboratories, high growth potential of anatomical pathology labs in emerging economies, and rising awareness regarding digital pathological systems are some key attributes that can provide new opportunities to players. Adoption rate of histology equipment is expected to gain substantial momentum owing to growing usage of technologically advanced biomarkers in diagnosing various diseases such as cancer and other infectious diseases.

Browse Full Research Report On Microtome Market: http://www.grandviewresearch.com/industry-analysis/microtome-market

Further Key Findings From the Report Suggest:

  • The global microtome market size was estimated at USD 48.6 million in 2016 and is expected to grow at a CAGR of 4.6% from 2017 to 2025
  • The microtome devices segment emerged as the largest product segment in 2016
  • Microtome accessories such as blades, blade holders, and clamps is anticipated to witness fastest growth over the next eight years
  • The Asia Pacific region is anticipated to witness lucrative growth over the next decade. It is expected to grow at a CAGR of 9.2% over the forecast period
  • Some of the key players are LLS ROWIAK LaserLabSolutions GmbH; Leica Biosystems Nussloch GmbH; Sakura.; MEDITE GmbH; SLEE medical GmbH; Boeckeler Instruments, Inc.; Nanolytik; S.M. Scientific Instruments Pvt. Ltd.; MICROS Austria Produktions-und Handelsges.m.b.H; AGD Biomedicals (P) Ltd.; Alltion; Amos Scientific Pty Ltd; and Thermo Fisher Scientific

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the global microtome market on the basis of product, technology, and region:

Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Microtome Devices
    • Rotary Microtome
    • Vibrating Microtome
    • Other Microtomes
  • Accessories

Technology Outlook (Revenue, USD Million, 2014 – 2025)

  • Fully Automated
  • Semi-Automated
  • Manual

Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/industry-analysis/microtome-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Enteral Feeding Devices Enormous Business Opportunities with Market Expansion Till 2020: Grand View Research, Inc.

The global Enteral Feeding Devices Market is expected to reach USD 2,720.8 million by 2020, according to a new study by Grand View Research, Inc. Growing global base of geriatric population and increasing prevalence of chronic diseases such as diabetes mellitus and pre-term births are some key factors expected to drive market growth over the next six years. The introduction of cost effective, portable and technologically advanced products such as low profile gastrostomy devices is also expected to accelerate the market penetration rates of these devices in emerging Asia Pacific and Latin American markets. Furthermore, the establishment of initiatives such as Stay Connected 2014 aimed at elevating user and patient awareness levels and facilitating the use of safety measures in the enteral feeding process is expected to present significant growth opportunity for industry participants.

enteral-feeding-devices-industry

Enteral feeding pumps dominated the overall market in terms of revenue share on account of their high market penetration and usage rates, with market revenue estimated at USD 1,115.3 million in 2013 and expected to grow at a CAGR of 6.4% from 2014 to 2020.

Browse Full Research Report on Enteral Feeding Devices Market: http://www.grandviewresearch.com/industry-analysis/enteral-feeding-devices-industry

Further key findings from the study suggest:

  • Europe was the largest regional market, with estimated revenue of USD 634.2 million in 2013. The presence of high prevalence of diabetes mellitus and other chronic disorders affecting the gastrointestinal system and a large base of geriatric population in this region attributes to its large market share.
  • North America followed Europe in terms of revenue share in 2013 at over 30.0%. High patient awareness levels, sophisticated healthcare infrastructure and high healthcare expenditures are some of the factors expected to serve this market as drivers.
  • Asia Pacific enteral feeding devices market is expected to exhibit the highest CAGR over the next six years owing to attributes such as the presence of high unmet medical needs, constantly improving healthcare infrastructure and patient awareness levels in countries such as India and China. Its market is expected to grow at a CAGR of 6.7% from 2014 to 2020 to reach USD 770.6 million by 2020.
  • The demand for percutaneous endoscopic gastrostomy devices and nasogastric tubes is expected to grow at a CAGR of over 5.6% and 5.2% from 2014 to 2020, respectively. Gastrostomy tube market revenue is expected to reach USD 206.3 million by 2020.
  • Key industry participants include Abbott Nutrition, Danone, Nestle, Fresenius, Boston Scientific Corporation, Kimberly Clark Corporation, Covidien Plc and Conmed Corporation.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the global enteral feeding devices market on the basis of product and region:

Enteral Feeding Devices Product Outlook
• Giving Set
• Enteral Feeding Pump
• Percutaneous Endoscopic Gastrostomy Device
• Low Profile Gastrostomy Device
• Nasogastric Tube
• Gastrostomy Tube
Enteral Feeding Devices Regional Outlook
• North America
• Europe
• Asia Pacific
• RoW

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-enteral-feeding-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com